stemphol: isolated from Stemphylium; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 170949 |
| CHEBI ID | 182211 |
| SCHEMBL ID | 18782422 |
| MeSH ID | M0233984 |
| Synonym |
|---|
| stemphol |
| 50982-33-7 |
| 2-butyl-5-pentylbenzene-1,3-diol |
| CHEBI:182211 |
| 70680-20-5 |
| nsc179487 |
| nsc-179487 |
| 2(or 5)-butyl-5(or 2)-phenyl-1,3-benzenediol |
| 1,3-benzenediol, 2(or 5)-butyl-5(or 2)-phenyl- |
| DTXSID10198982 |
| SCHEMBL18782422 |
| 2-butyl-5-pentylresorcinol |
| AS-58877 |
| ncgc00384855-01!2-butyl-5-pentylbenzene-1,3-diol |
| W19548 |
| AKOS034833420 |
| Class | Description |
|---|---|
| resorcinols | Any benzenediol in which the two hydroxy groups are meta to one another. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||